MARKET

SCNI

SCNI

Scinai Immunotherapeutics Ltd.
NASDAQ
0.7383
+0.0357
+5.08%
Closed 19:43 12/04 EST
OPEN
0.7500
PREV CLOSE
0.7026
HIGH
0.7500
LOW
0.7265
VOLUME
12.20K
TURNOVER
0
52 WEEK HIGH
11.49
52 WEEK LOW
0.5010
MARKET CAP
3.21M
P/E (TTM)
-0.4357
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at SCNI last week (1127-1201)?
Weekly Report · 1d ago
Weekly Report: what happened at SCNI last week (1120-1124)?
Weekly Report · 11/27 09:37
Scinai Immunotherapeutics Ltd.: Report of foreign issuer
Press release · 11/20 16:00
Scinai Immunotherapeutics regains compliance with stockholders' equity rule
Healthcare scinai immunotherapeutics regains compliance with stockholders' equity rule. Nasdaq may subject the company to delisting if it is not in compliance with listing rules. Scinaa has received a letter regarding non-compliance with a minimum bid price requirement.
Seeking Alpha · 11/20 12:37
Weekly Report: what happened at SCNI last week (1113-1117)?
Weekly Report · 11/20 09:37
Scinai Immunotherapeutics Ltd.: Report of foreign issuer
Press release · 11/13 18:00
Weekly Report: what happened at SCNI last week (1106-1110)?
Weekly Report · 11/13 09:35
Scinai Immunotherapeutics Ltd.: Report of foreign issuer
Press release · 11/07 14:00
More
About SCNI
Scinai Immunotherapeutics Ltd, formerly known as BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company that is principally focused on developing, manufacturing, and commercializing medical products for the prevention and treatment of autoimmune and infectious diseases but also for other illnesses. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The Company's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.

Webull offers Scinai Immunotherapeutics Ltd - ADR stock information, including NASDAQ: SCNI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SCNI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SCNI stock methods without spending real money on the virtual paper trading platform.